TABLE 2.
Characteristics | n (%) |
---|---|
Vaccine offered | |
Hepatitis B | 60 (76.9) |
Hepatitis A | 54 (69.2) |
HPV | 52 (66.7) |
Influenza | 44 (56.4) |
Tdap | 36 (46.2) |
Meningococcal | 34 (43.6) |
Vaccine funding | |
Vaccines for Children | 37 (47.4) |
317 funding | 9 (11.5) |
Grants/donations | 20 (25.6) |
Insurance mechanisms (private and/or public) | 26 (33.3) |
Patient out-of-pocket for entire cost | 17 (21.8) |
Other/none | 29 (37.2) |